ATORVASTATIN CALCIUM
- Product NDC
- 55700-871
- 11-digit product format
- 557000871
- Labeler code
- 55700
- Product ID
- 55700-871_53c649ce-73ad-48dc-b953-08779b3631d9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA207687
- Marketing category
- ANDA
- Marketing start
- 2020-07-31
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-871-30 | 55700087130 | 30 TABLET, FILM COATED in 1 BOTTLE (55700-871-30) | 2020-07-31 | 0000-00-00 | No | No | Current |